1. Home
  2. Vivek Oberoi slammed for 'bizarre' tweet about Aishwarya Rai's relationship

Vivek Oberoi slammed for 'bizarre' tweet about Aishwarya Rai's relationship

Agencies
May 20, 2019

Mumbai, May 20: While the whole nation is looking forward to the final verdict of 2019 Lok Sabha elections, Vivek Oberoi decided to take a dig at the exit polls with a tasteless joke referring to his ex-girlfriend Aishwarya Rai and her relationships, and is now being slammed for it.

Earlier today, Vivek tweeted a collage of three images featuring him, Aishwarya, Salman Khan, Abhishek Bachchan, and Aishwarya's seven-year-old daughter Aaradhya.

The post referred to Salman and Aishwarya's relationship as the 'opinion poll', Vivek and Aishwarya's affair as the 'exit poll' and her current family with husband Abhishek and daughter Aaradhya as the 'final result.'

While the actor might have posted the tweet thinking it is funny, the Twitterverse did not share the same feeling. Many called him out for posting the bizarre tweet.

"This is in such poor taste.. ones personal life is not to be discussed here.. remember there are 4 individuals who are father/ mother/ brother /sister .. and everyone has moved on .. shame," a user commented on the post.

Comparing the way Salman addresses Aishwarya in public with Vivek's tweet, a user wrote, "One there is Salman Khan who doesn't event take Aishwarya's name without her full name (i.e. Aishwarya Rai Bachchan) and then there is vivek oberoi who is so shameless that he is not only sharing such a disrespectful meme but also dragging a minor into this. Shame on you."

"Extremely absurd of you to tweet this!! Disappointing!," wrote another.

Another user wrote, "You tweeting this pic is a sign that Aishwarya made a sensible decision."

"This is disgusting...She has a daughter now and is living a happily married life. A fan of vivek oberoi but this is disgusting," another user commented.

Calling the tweet disgusting and disappointing many asked the actor to take the tweet down and apologise.

Vivek is currently awaiting the release of his film, 'PM Narendra Modi', a biopic on the life of India's Prime Minister. After many delays, the biopic is finally set to release on May 24.

Earlier today, Union Minister Nitin Gadkari unveiled a new poster of PM Narendra Modi featuring the latest release date.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 18,2020

Mumbai, Jan 18: Actor Shabana Azmi was injured in an accident on Saturday afternoon on the Mumbai-Pune Expressway in Maharashtra's Raigad district, an official said.

The incident took place around 3.30 pm near Khalapur, over 60 km from Mumbai, when the car in which she was traveling rammed into a truck, said Raigad Superintendent of Police Anil Paraskar.

She was rushed to MGM hospital in Navi Mumbai and was undergoing treatment, he said.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

Patna, Aug 3: Bihar DGP Gupteshwar Pandey on Sunday charged that Vinay Tiwari, the IPS officer from Patna who is in Mumbai to probe a case related to Bollywood actor Sushant Singh Rajput's death, has been "forcibly quarantined" by civic authorities in the metropolis.

Tiwari is heading a Bihar Police team which is in Mumbai to investigate an ''abetment to suicide'' case on the basis of a complaint filed by the late actor's father in Patna.

"IPS officer Vinay Tiwari reached Mumbai today from Patna on official duty to lead the police team there but he has been forcibly quarantined by BMC officials at 11 PM today," Bihar Director General of Police (DGP) Pandey tweeted.

"He was not provided accommodation in the IPS mess, despite request, and was staying in a Guest House in Goregaon," he said.

Sushant's sister Shweta Singh Kirti has tweeted, " What? Is this even for real? How can an officer sent on duty be quarantined for 14 Days?".

Rajput, 34, was found hanging from the ceiling of his Bandra residence on June 24 last.

Last month, Rajput's father lodged an FIR here of abetment to suicide naming actress Rhea Chakraborty, said to be close to the deceased Patna-born actor, and her family members as accused. Tiwari was posted as the City SP (East) in Patna.

The Mumbai Police, which is also probing the death case, have so far recorded statements of nearly 40 people, including those from Rajput's family, his cook and people from the film industry that include filmmaker Mahesh Bhatt, film critic Rajeev Masand, director-producer Sanjay Leela Bhansali and filmmaker Aditya Chopra.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.